do glp 1 drugs affect sex drive Clinical review of how glucagon-like peptide-1 agonist obesity medications decrease sexual desire, and a biopsychosocial model for why we don't 'see' it Exclusive | We lost weight

Progressive Dosing Protocols Rather than maintaining a static dose throughout a research cycle, progressive protocols involve systematic dose adjustments: Weeks 1-2 : Start at 15mg daily to assess baseline tolerance and response Weeks 3-4 : Increase to 25mg daily if well-tolerated Weeks 5-8 : Potentially increase to 30-35mg based on goals and response Weeks 9-12 : Maintain optimal dose identified during earlier weeks This approach allows for individualized optimization while maintaining safety margins

avoid unnecessary calcium if constipation appears

doi: 10.3389/fendo.2025.1575087, PMID: [DOI] [PMC free article] [PubMed] [Google Scholar] 148

Gemss Asadi et al